DOXIMITY INC-CLASS A (DOCS) Forecast, Price Target & Analyst Ratings

NYSE:DOCS • US26622P1075

Current stock price

24.41 USD
-0.39 (-1.57%)
At close:
24.41 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DOXIMITY INC-CLASS A (DOCS).

Forecast Snapshot

Consensus Price Target

Price Target
$44.25
+ 81.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q4 / 2026
EPS Estimate
$0.29
Revenue Estimate
146.77M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.38%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$44.25
Upside
+ 81.27%
From current price of $24.41 to mean target of $44.25, Based on 29 analyst forecasts
Low
$25.25
Median
$40.80
High
$82.95

Price Target Revisions

1 Month
-31.04%
3 Months
-36.60%

Price Target Summary

29 Wall Street analysts provided a forecast for the next 12 months for DOCS. The average price target is 44.25 USD. This implies a price increase of 81.27% is expected in the next year compared to the current price of 24.41.
The average price target has been revised downward by 36.6% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DOCS Current Analyst RatingDOCS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

DOCS Historical Analyst RatingsDOCS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
81.38%
DOCS was analyzed by 29 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about DOCS.
In the previous month the buy percentage consensus was at a similar level.
DOCS was analyzed by 29 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-18Freedom Capital MarketsInitiate Buy
2026-03-09RBC CapitalReiterate Outperform -> Outperform
2026-02-20JP MorganMaintains Neutral -> Neutral
2026-02-20Piper SandlerMaintains Overweight -> Overweight
2026-02-11BarclaysMaintains Overweight -> Overweight
2026-02-10MizuhoMaintains Neutral -> Neutral
2026-02-09Canaccord GenuityUpgrade Hold -> Buy
2026-02-09Goldman SachsMaintains Neutral -> Neutral
2026-02-06BTIGMaintains Buy -> Buy
2026-02-06NeedhamMaintains Buy -> Buy
2026-02-06Wells FargoMaintains Overweight -> Overweight
2026-02-06Truist SecuritiesMaintains Buy -> Buy
2026-02-06JP MorganUpgrade Underweight -> Neutral
2026-02-06Morgan StanleyMaintains Overweight -> Overweight
2026-02-06Piper SandlerMaintains Overweight -> Overweight
2026-01-20Wells FargoUpgrade Equal-Weight -> Overweight
2026-01-08KeybancMaintains Overweight -> Overweight
2025-12-15Morgan StanleyUpgrade Equal-Weight -> Overweight
2025-12-09BarclaysInitiate Overweight
2025-11-21Raymond JamesUpgrade Outperform -> Strong Buy
2025-11-13BMO CapitalInitiate Market Perform
2025-11-10Canaccord GenuityMaintains Hold -> Hold
2025-11-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-27B of A SecuritiesUpgrade Neutral -> Buy
2025-10-10JP MorganDowngrade Neutral -> Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q4 / 2026
EPS Estimate
$0.29
Revenue Estimate
146.77M
Revenue Q2Q
6.13%
EPS Q2Q
-24.25%
Number of Analysts
24

Next Earnings Revisions

Revenue (1 Month)
-0.60%
Revenue (3 Months)
-4.28%
EPS (1 Month)
-4.46%
EPS (3 Months)
-12.44%

Next Earnings Summary

DOCS is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 0.29 USD and the consensus revenue estimate is 146.77M USD.
The next earnings revenue estimate has been revised downward by 4.28% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
DOCS revenue by date.DOCS revenue by date.
419.1M
22.01%		475.422M
13.44%		570.399M
19.98%		656.35M
15.07%		715.54M
9.02%		784.06M
9.58%		840.88M
7.25%		1.009B
19.99%		1.128B
11.79%		1.253B
11.08%
EBITDA
YoY % growth
DOCS ebitda by date.DOCS ebitda by date.
135.4M
14.26%		182.079M
34.47%		240.763M
32.23%		363.04M
50.79%		382.75M
5.43%		422.95M
10.50%		463.97M
9.70%		563.75M
21.51%		632.81M
12.25%		705.94M
11.56%
EBIT
YoY % growth
DOCS ebit by date.DOCS ebit by date.
125.1M
10.22%		171.814M
37.34%		230.104M
33.93%		354.89M
54.23%		370.05M
4.27%		418.3M
13.04%		485.62M
16.09%		545.7M
12.37%		612M
12.15%		682.48M
11.52%
Operating Margin
DOCS operating margin by date.DOCS operating margin by date.
29.85%36.14%40.34%54.07%51.72%53.35%57.75%54.08%54.26%54.47%
EPS
YoY % growth
DOCS eps by date.DOCS eps by date.
0.73
-8.75%		0.95
30.14%		1.41
48.42%		1.58
11.83%		1.66
5.27%		1.84
11.09%		1.99
7.85%		2.46
23.59%		2.82
14.52%		3.21
14.13%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.29
-24.25%		0.35
-2.11%		0.46
1.36%		0.50
8.72%		0.38
31.14%		0.44
24.46%		0.46
0.63%		0.56
12.18%		0.48
26.99%
Revenue
Q2Q % growth		146.77M
6.13%		157.67M
8.06%		188.69M
11.97%		206.11M
11.38%		171.37M
16.76%		174.13M
10.44%		192.05M
1.78%		220.41M
6.94%		191.99M
12.03%
EBITDA
Q2Q % growth		65.557M
10.48%		82.375M
43.73%		105.87M
51.36%		120.51M
46.70%		89.544M
36.59%		94.519M
14.74%		111.06M
4.90%		132.4M
9.87%		102.53M
14.50%
EBIT
Q2Q % growth		64.55M
32.60%		78.47M
43.94%		102.84M
61.49%		114.57M
59.36%		83.647M
29.58%		89.28M
13.78%		124.63M
21.19%		125.45M
9.50%		95.433M
14.09%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DOCS Yearly Revenue VS EstimatesDOCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
DOCS Yearly EPS VS EstimatesDOCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.36%
EPS Next 5 Year
11.76%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.76%
Revenue Next 5 Year
11.82%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
11.16%
EBIT Next 5 Year
12.86%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DOXIMITY INC-CLASS A / DOCS Forecast FAQ

What is the price target for DOCS stock?

29 analysts have analysed DOCS and the average price target is 44.25 USD. This implies a price increase of 81.27% is expected in the next year compared to the current price of 24.41.

What is the next earnings date for DOCS stock?

DOXIMITY INC-CLASS A (DOCS) will report earnings on 2026-05-13, after the market close.

What are the consensus estimates for DOXIMITY INC-CLASS A (DOCS) next earnings?

The consensus EPS estimate for the next earnings of DOXIMITY INC-CLASS A (DOCS) is 0.29 USD and the consensus revenue estimate is 146.77M USD.

What is the number of analysts for DOCS stock?

The number of analysts covering DOXIMITY INC-CLASS A (DOCS) is 29.